Pharmaceuticals, Biotechnology and Life Sciences
EDINBURGH, Scotland–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/PromPT?src=hash" target="_blank"gt;#PromPTlt;/agt;–Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for…
Partnership creates promise for improving the health of those living with this debilitating and costly disease SAN FRANCISCO–(BUSINESS WIRE)–Virta Health,…
U.S. FDA Remains Committed to Streamline & Accelerate Drug Development using Model-Informed Drug Development (MIDD) technology RESEARCH TRIANGLE PARK, N.C.–(BUSINESS…
The European Commission has approved two of Celgene’s IMiD®-based combination regimens: REVLIMID in combination with bortezomib and dexamethasone (RVd) in…
A major step towards clinical trials PARIS–(BUSINESS WIRE)–PEP-Therapy, a biotechnology company developing peptides as targeted therapies for oncology, announces that…
BRISBANE, Calif.–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its Chief…
Trudy H. Grossman, Ph.D., and Roger Léger, Ph.D., named to executive leadership positions FARMINGTON, Conn.–(BUSINESS WIRE)–Azitra, Inc., a clinical-stage medical…
Accepted abstracts highlight additional data from phase 3 ARIEL3 clinical trial, genomic data from phase 2 TRITON2 clinical trial, and…
Access to Resero’s TurboToxicology™ will provide faster delivery of high-quality toxicology reports WILMINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CRL&src=ctag" target="_blank"gt;$CRLlt;/agt; lt;a href="https://twitter.com/hashtag/LIFEatCRL?src=hash" target="_blank"gt;#LIFEatCRLlt;/agt;–Charles…
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., is proud to announce that…